These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 23722930)

  • 1. Review: toxicometabolomics.
    Bouhifd M; Hartung T; Hogberg HT; Kleensang A; Zhao L
    J Appl Toxicol; 2013 Dec; 33(12):1365-83. PubMed ID: 23722930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabonomics and toxicology.
    Zhao L; Hartung T
    Methods Mol Biol; 2015; 1277():209-31. PubMed ID: 25677156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance of metabolomics.
    Bouhifd M; Beger R; Flynn T; Guo L; Harris G; Hogberg H; Kaddurah-Daouk R; Kamp H; Kleensang A; Maertens A; Odwin-DaCosta S; Pamies D; Robertson D; Smirnova L; Sun J; Zhao L; Hartung T
    ALTEX; 2015; 32(4):319-26. PubMed ID: 26536290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food for Thought ... on mapping the human toxome.
    Hartung T; McBride M
    ALTEX; 2011; 28(2):83-93. PubMed ID: 21625825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human toxome project.
    Bouhifd M; Andersen ME; Baghdikian C; Boekelheide K; Crofton KM; Fornace AJ; Kleensang A; Li H; Livi C; Maertens A; McMullen PD; Rosenberg M; Thomas R; Vantangoli M; Yager JD; Zhao L; Hartung T
    ALTEX; 2015; 32(2):112-24. PubMed ID: 25742299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic network analysis of estrogen-stimulated MCF-7 cells: a comparison of overrepresentation analysis, quantitative enrichment analysis and pathway analysis versus metabolite network analysis.
    Maertens A; Bouhifd M; Zhao L; Odwin-DaCosta S; Kleensang A; Yager JD; Hartung T
    Arch Toxicol; 2017 Jan; 91(1):217-230. PubMed ID: 27039105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Prueitt RL; Beck BD
    Hum Exp Toxicol; 2010 Jan; 29(1):7-9. PubMed ID: 20061461
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high-throughput metabolomics in vitro platform for the characterization of hepatotoxicity.
    Ramirez-Hincapie S; Birk B; Ternes P; Giri V; Haake V; Herold M; Zickgraf FM; Verlohner A; Huener HA; Kamp H; Driemert P; Landsiedel R; Richling E; Funk-Weyer D; van Ravenzwaay B
    Cell Biol Toxicol; 2023 Dec; 39(6):2899-2917. PubMed ID: 37138123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects and challenges of multi-omics data integration in toxicology.
    Canzler S; Schor J; Busch W; Schubert K; Rolle-Kampczyk UE; Seitz H; Kamp H; von Bergen M; Buesen R; Hackermüller J
    Arch Toxicol; 2020 Feb; 94(2):371-388. PubMed ID: 32034435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathway Analysis for Targeted and Untargeted Metabolomics.
    Karnovsky A; Li S
    Methods Mol Biol; 2020; 2104():387-400. PubMed ID: 31953827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in "omics" technologies for toxicological research].
    Inadera H; Uchida M; Shimomura A
    Nihon Eiseigaku Zasshi; 2007 Jan; 62(1):18-31. PubMed ID: 17334089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Strategies for Biological Interpretation of Metabolomics Data.
    Xia J
    Adv Exp Med Biol; 2017; 965():191-206. PubMed ID: 28132181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sensitivity of metabolomics versus classical regulatory toxicology from a NOAEL perspective.
    van Ravenzwaay B; Montoya GA; Fabian E; Herold M; Krennrich G; Looser R; Mellert W; Peter E; Strauss V; Walk T; Kamp H
    Toxicol Lett; 2014 May; 227(1):20-8. PubMed ID: 24657160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of metabolomics for the discovery of new biomarkers of effect.
    van Ravenzwaay B; Cunha GC; Leibold E; Looser R; Mellert W; Prokoudine A; Walk T; Wiemer J
    Toxicol Lett; 2007 Jul; 172(1-2):21-8. PubMed ID: 17614222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions.
    Araújo AM; Carvalho F; Guedes de Pinho P; Carvalho M
    Metabolites; 2021 Oct; 11(10):. PubMed ID: 34677407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches in metabolomics for regulatory toxicology applications.
    Olesti E; González-Ruiz V; Wilks MF; Boccard J; Rudaz S
    Analyst; 2021 Mar; 146(6):1820-1834. PubMed ID: 33605958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics in toxicology and preclinical research.
    Ramirez T; Daneshian M; Kamp H; Bois FY; Clench MR; Coen M; Donley B; Fischer SM; Ekman DR; Fabian E; Guillou C; Heuer J; Hogberg HT; Jungnickel H; Keun HC; Krennrich G; Krupp E; Luch A; Noor F; Peter E; Riefke B; Seymour M; Skinner N; Smirnova L; Verheij E; Wagner S; Hartung T; van Ravenzwaay B; Leist M
    ALTEX; 2013; 30(2):209-25. PubMed ID: 23665807
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.